Abstracts – RGCON 2016
Ovary: Oral Abstract: To assess the role of addition of bevacizumab therapy to carboplatin and paclitaxel as frontline treatment of epithelial ovarian cancer
Volume 02 | Issue Supplement 1 | July 2016
Disclaimer:
This article was originally published by Wolters Kluwer – Medknow and was migrated to Scientific Scholar after the change of Publisher.
This article was originally published by Wolters Kluwer – Medknow and was migrated to Scientific Scholar after the change of Publisher.